Last reviewed · How we verify
Vinmec Healthcare System — Portfolio Competitive Intelligence Brief
1 marketed
0 filed
0 Phase 3
1 Phase 2
0 Phase 1
Live · 30-min refresh
Portfolio leaders (marketed + Phase 3 / filed)
| Drug | Generic | Phase | Class | Target | Area | First approval |
|---|---|---|---|---|---|---|
| saline 09% | saline 09% | marketed | Crystalloid fluid / Electrolyte replacement solution | Supportive Care / Fluid & Electrolyte Management |
Therapeutic area mix
- Supportive Care / Fluid & Electrolyte Management · 1
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Competitive overlap (companies sharing drug classes)
- Dr. Waseem Ullah · 1 shared drug class
- Fayoum University Hospital · 1 shared drug class
- GCP-Service International West GmbH · 1 shared drug class
- Hospital Central "Dr. Ignacio Morones Prieto" · 1 shared drug class
- Hospital Italiano de Buenos Aires · 1 shared drug class
- Hvidovre University Hospital · 1 shared drug class
- Hédi Chaker Hospital · 1 shared drug class
- Kecioren Education and Training Hospital · 1 shared drug class
Subscribe to ongoing alerts
Every new pipeline event for Vinmec Healthcare System:
- Vinmec Healthcare System pipeline updates — RSS
- Vinmec Healthcare System pipeline updates — Atom
- Vinmec Healthcare System pipeline updates — JSON
Cite this brief
Drug Landscape (2026). Vinmec Healthcare System — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/vinmec-healthcare-system. Accessed 2026-05-16.